pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
910
stories
Jul 15, 26
STAT+: Celcuity’s breast cancer drug approved, its first
stat
Jul 15, 26
Deaths from coronary artery disease have fallen, but more progress is within reach
stat
Jul 15, 26
Kelun’s Merck-partnered ADC notches late-stage NSCLC win alongside Keytruda
biospace
Jul 15, 26
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
biopharma dive
Jul 15, 26
STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more
stat
Jul 14, 26
STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access
stat
Jul 14, 26
Celcuity wins approval for breast cancer drug Revtorpyk
endpoints
Jul 14, 26
STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last year
stat
Jul 14, 26
Erasca's $550M offering; Summit sells an antibiotic
endpoints
Jul 14, 26
STAT+: Akero team, backed by Fairmount, launches new immunology company
stat
Jul 14, 26
STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and more
stat
Jul 14, 26
STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study shows
stat
Jul 14, 26
AstraZeneca to take rights to Dizal's lung cancer pill Zegfrovy
endpoints
Jul 14, 26
12 ideas for tackling the U.S. alcohol epidemic
stat
Jul 14, 26
STAT+: Drug metabolism AI competition results show that bigger may not always be better
stat
Jul 14, 26
Experts: Industry to benefit from focused follow-ups, major deficiency letters in MDUFA VI
raps
Jul 13, 26
STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
stat
Jul 13, 26
Freenome colorectal cancer test data improve on earlier results
biopharma dive
Jul 13, 26
STAT+: Dementia study replicates promising outcomes following risk-reduction strategies
stat
Jul 13, 26
Agenus surges on study pivot; Apnimed lines up an IPO
biopharma dive
Jul 13, 26
Martha Lillard, last U.S. polio patient using iron lung, dies at 78 in Oklahoma
stat
Jul 13, 26
Tris Pharma's CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trial
endpoints
Jul 13, 26
STAT+: All eyes on data on Biogen’s tau therapy
stat
Jul 13, 26
STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and more
stat
Jul 13, 26
Caregivers brace for pay cuts, and maybe homelessness
stat
Jul 13, 26
Biotech startup funding gap widens despite rebound in VC investment
biopharma dive
Jul 13, 26
Opinion: Is there a doctor on board? Yes, and airlines depend on it
stat
Jul 13, 26
STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come
stat
Jul 10, 26
FDA rejects Hengrui-Elevar liver cancer drug combo for third time
endpoints
Jul 10, 26
GSK, Hansoh ADC extends survival in lung cancer study
biopharma dive
← prev
page 13 of 31
next →
